About: http://webisa.webdatacommons.org/162563419

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	He adds, We view CMIC's licensing collaborations with Ucyclyd Pharma, Inc. and Orphan Europe SARL as examples of their dedication to developing treatments for rare diseases.
http://www.w3.org/ns/prov#wasQuotedFrom	dyax.com